SeouLin seeks international hepatitis B test patent

Published: 2007-10-30 06:56:00

Updated: 2007-10-30 06:56:00

SeouLin Bioscience, local biopharmaceutical firm, said it has filed an international patent application for detecting mutants of hepatitis B virus, a company official said.

The company's patent may be applicable in developing a specific chip by incorporating it with BioMEMS technology.

The ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK